Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis

被引:47
|
作者
Palman, Jason [1 ]
Shoop-Worrall, Stephanie [2 ]
Hyrich, Kimme [2 ]
McDonagh, Janet E. [2 ]
机构
[1] Royal Manchester Childrens Hosp, Dept Paediat Rheumatol, Oxford Rd, Manchester M13 9WL, Lancs, England
[2] Univ Manchester, ARUK Ctr Epidemiol, Div Musculoskeletal & Dermatol Sci, Stopford Bldg, Manchester M13 9PT, Lancs, England
来源
基金
英国医学研究理事会;
关键词
Juvenile idiopathic arthritis; Outcomes; Adults with JIA; Transitional care; Proxy reporting; Patient-reported outcome measures; QUALITY-OF-LIFE; TERM FOLLOW-UP; RHEUMATOID-ARTHRITIS; SOCIOECONOMIC-STATUS; SEASONAL-VARIATION; HEALTH OUTCOMES; PARVOVIRUS B19; YOUNG-ADULTS; CHILDREN; POPULATION;
D O I
10.1016/j.berh.2018.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Juvenile idiopathic arthritis (JIA) is the most common inflammatory joint condition of childhood and represents seven JIA subtypes characterised by distinct clinical and laboratory variables. Genetic and environmental factors are known to influence JIA, although many unanswered questions remain. Measurement of health outcomes in JIA is imperative for both clinical practice and research. Patient -reported outcomes present particular challenges in paediatric rheumatology in view of the importance of collecting reports from both the child/ young person and the parent. Another challenge is the need for continuity of outcome measurement across the paediatric adult interface during the process of transition in terms of both measurement tools and the mechanisms in the system to facilitate tracking of the young person into adult care. Finally, the need for adults with JIA to be seen as a distinct group in adult rheumatology practice is important for both service provision and outcome research. Crown Copyright (C) 2018 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:206 / 222
页数:17
相关论文
共 50 条
  • [31] Epidemiology of juvenile idiopathic arthritis in Alsace, France
    Danner, Stephanie
    Sordet, Christelle
    Terzic, Joelle
    Donato, Lionel
    Velten, Michel
    Fischbach, Michel
    Sibilia, Jean
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (07) : 1377 - 1381
  • [32] Prognostic risk factors in juvenile idiopathic arthritis and consequences for treatment
    Martini, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 30 - 30
  • [33] PREVALENCE AND RISK FACTORS OF OSTEOPOROSIS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Bettaieb, H.
    Ferjani, H.
    Maatallah, K.
    Boussaa, H.
    Kaffel, D.
    Hamdi, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1400 - 1400
  • [34] Assessment of Cardiovascular Risk Factors in Patients with Juvenile Idiopathic Arthritis
    Gruca, Marta
    Zamojska, Justyna
    Niewiadomska-Jarosik, Katarzyna
    Wosiak, Agnieszka
    Stasiak, Aleksandra
    Sikorska, Karolina
    Stanczyk, Jerzy
    Smolewska, Elzbieta
    [J]. NUTRIENTS, 2023, 15 (07)
  • [35] Epidemiology of juvenile rheumatoid arthritis in the Americas -: An update
    Rosé, CD
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2006, 12 (03) : 129 - 130
  • [36] UPDATE ON DIAGNOSIS AND MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS
    Petty, R.
    [J]. RHEUMATOLOGY, 2012, 51 : I10 - I10
  • [37] Update on the medical treatment of juvenile idiopathic arthritis
    Hashkes P.J.
    Laxer R.M.
    [J]. Current Rheumatology Reports, 2006, 8 (6) : 450 - 458
  • [38] Update on biologicals for treatment of juvenile idiopathic arthritis
    Horneff, Gerd
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (03) : 361 - 376
  • [39] Update on the pathogenesis and treatment of juvenile idiopathic arthritis
    Giancane, Gabriella
    Alongi, Alessandra
    Ravelli, Angelo
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (05) : 523 - 529
  • [40] An Epidemic: Severe Lung Disease in Patients with Systemic Juvenile Idiopathic Arthritis, Risk Factors and Predictors
    Yasin, Shima
    Towe, Christopher
    Fall, Ndate
    Grom, Alexei
    Schulert, Grant
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70